tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PRQR Stock Latest News

ProQR’s Axiomer Technology and AX-0810: A Promising Buy Rating with Increased Price Target
RatingsProQR’s Axiomer Technology and AX-0810: A Promising Buy Rating with Increased Price Target
11d ago
PRQR
ProQR Therapeutics price target raised to $12 from $10 at H.C. Wainwright
PremiumThe Fly
ProQR Therapeutics price target raised to $12 from $10 at H.C. Wainwright
14d ago
PRQR
ProQR Therapeutics files to sell 3.52M ordinary shares for holders
PremiumThe Fly
ProQR Therapeutics files to sell 3.52M ordinary shares for holders
15d ago
PRQR
ProQR Therapeutics Reports 2024 Results and Pipeline Progress
PremiumCompany Announcements
ProQR Therapeutics Reports 2024 Results and Pipeline Progress
15d ago
6K
PRQR
ProQR Therapeutics reports FY24 EPS (EUR 0.32) vs (EUR 0.35) last year
PremiumThe Fly
ProQR Therapeutics reports FY24 EPS (EUR 0.32) vs (EUR 0.35) last year
15d ago
PRQR
ProQR’s Undervalued Potential: Buy Rating on Promising Pipeline and Market Opportunity
PremiumRatingsProQR’s Undervalued Potential: Buy Rating on Promising Pipeline and Market Opportunity
21d ago
PRQR
ProQR Therapeutics upgraded to Buy from Neutral at Citi
Premium
The Fly
ProQR Therapeutics upgraded to Buy from Neutral at Citi
21d ago
PRQR
PRQR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PRQR Earnings this Week: How Will it Perform?
1M ago
PRQR
ProQR Therapeutics initiated with a Buy at JonesResearch
PremiumThe Fly
ProQR Therapeutics initiated with a Buy at JonesResearch
2M ago
PRQR
ProQR Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe Fly
ProQR Therapeutics initiated with an Outperform at Oppenheimer
3M ago
PRQR
ProQR Therapeutics Advances Axiomer RNA-Editing Platform with Strategic Partnerships
PremiumCompany Announcements
ProQR Therapeutics Advances Axiomer RNA-Editing Platform with Strategic Partnerships
4M ago
6K
PRQR
ProQR Secures $8.1 Million for Rett Syndrome RNA Therapy
PremiumCompany Announcements
ProQR Secures $8.1 Million for Rett Syndrome RNA Therapy
4M ago
6K
PRQR
ProQR Therapeutics announces $8.1M in new funding from RSRT
PremiumThe FlyProQR Therapeutics announces $8.1M in new funding from RSRT
4M ago
PRQR
ProQR Strengthens RNA Editing Team with Key Appointment
Premium
Company Announcements
ProQR Strengthens RNA Editing Team with Key Appointment
4M ago
6K
PRQR
ProQR Therapeutics appoints Beal as Chief ADAR Scientist
Premium
The Fly
ProQR Therapeutics appoints Beal as Chief ADAR Scientist
4M ago
PRQR
ProQR Highlights RNA Innovations in Upcoming Event
PremiumCompany Announcements
ProQR Highlights RNA Innovations in Upcoming Event
4M ago
6K
PRQR
ProQR Therapeutics price target raised to $8 from $5 at JMP Securities
PremiumThe Fly
ProQR Therapeutics price target raised to $8 from $5 at JMP Securities
4M ago
PRQR
ProQR Therapeutics Highlights Q3 2024 Financial Results
PremiumCompany Announcements
ProQR Therapeutics Highlights Q3 2024 Financial Results
4M ago
PRQR
ProQR Therapeutics price target raised to $10 from $5 at H.C. Wainwright
PremiumThe Fly
ProQR Therapeutics price target raised to $10 from $5 at H.C. Wainwright
5M ago
PRQR
ProQR Therapeutics price target raised to $4 from $2.50 at Chardan
PremiumThe FlyProQR Therapeutics price target raised to $4 from $2.50 at Chardan
5M ago
PRQR
ProQR Therapeutics Shows Revenue Growth Amid Financial Challenges
Premium
Company Announcements
ProQR Therapeutics Shows Revenue Growth Amid Financial Challenges
5M ago
6K
PRQR
ProQR Therapeutics reports Q3 EPS (EUR 0.10) vs. (EUR 0.07) last year
Premium
The Fly
ProQR Therapeutics reports Q3 EPS (EUR 0.10) vs. (EUR 0.07) last year
5M ago
PRQR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >